SCHEMBL2242102

SCHEMBL2242102

CC(=NO)c1ccc(C(=O)NCc2ccc(Oc3ccccc3)s2)c(N)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLKB1 P03952 2/20 0.36
TDP1 Q9NUW8 2/20 0.35
ALDH1A1 P00352 4/20 0.35
KDM4E B2RXH2 2/20 0.35
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MAPK8 P45983 3/20 0.34
GALR3 O60755 1/20 0.33
NR2F2 P24468 1/20 0.33
MAPK14 Q16539 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.32
HPGD P15428 2/20 0.32
GAA P10253 1/20 0.32
HTT P42858 1/20 0.32
ATM Q13315 1/20 0.32
CA2 P00918 1/20 0.32
CA4 P22748 1/20 0.32
USP2 O75604 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2242096 1.00 KLKB1 (0.36) KLKB1TDP1ALDH1A1KDM4EMEN1
SCHEMBL2242092 1.00 KLKB1 (0.36) KLKB1TDP1ALDH1A1KDM4EMEN1
SCHEMBL1680766 0.90 KLKB1 (0.38) KLKB1TDP1ALDH1A1KDM4EMEN1
SCHEMBL920425 0.84 KLKB1 (0.40) KLKB1TDP1ALDH1A1KDM4EMEN1
SCHEMBL1680856 0.84 ALDH1A1 (0.40) KLKB1TDP1ALDH1A1KDM4EMEN1
SCHEMBL1680399 0.83 KLKB1 (0.37) KLKB1TDP1ALDH1A1KDM4EMEN1
SCHEMBL1680840 0.82 KLKB1 (0.39) KLKB1TDP1ALDH1A1KDM4EMEN1
SCHEMBL1680806 0.82 KDM4E (0.38) KLKB1TDP1ALDH1A1KDM4EMAPT
SCHEMBL1680407 0.82 MAPK8 (0.40) KLKB1TDP1ALDH1A1KDM4EMEN1
SCHEMBL921262 0.82 MAPK8 (0.38) KLKB1TDP1ALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110195999-A1 NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND NAKAMOTO KAZUTAKA 2011-08-11 US disclosed
US-20090227799-A1 Novel Antimalarial Agent Containing Heterocyclic Compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-09-10 US disclosed
EP-1669348-A1 NOVEL ANTIFUNGAL AGENT COMPRISING HETEROCYCLIC COMPOUND Eisai Co., Ltd. (JP) 2006-06-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110195999-A1 NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND ERG28, CYP51A1, XPO1 KLKB1 3404/4885TDP1 3095/4885ALDH1A1 1677/4885
US-20090227799-A1 Novel Antimalarial Agent Containing Heterocyclic Compound XPO1, THPO, G6PD KLKB1 4258/4885TDP1 2562/4885ALDH1A1 1926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.